← Back to Search

Stem Cell Therapy

MultiStem for COVID-19 Induced ARDS (MACoVIA Trial)

Phase 2 & 3
Waitlist Available
Research Sponsored by Healios K.K.
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up up to 5 years

Summary

This trial is testing MultiStem therapy, which uses special cells to help heal and reduce inflammation, in patients with moderate to severe ARDS, including those caused by COVID-19. The therapy aims to calm the body's response and support lung repair. MultiStem therapy has shown promise in reducing inflammation and aiding lung repair in severe COVID-19 cases.

Eligible Conditions
  • Acute Respiratory Distress Syndrome (ARDS)

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~up to 5 years
This trial's timeline: 3 weeks for screening, Varies for treatment, and up to 5 years for reporting.

Treatment Details

Trial Design

2Treatment groups
Experimental Treatment
Placebo Group
Group I: MultiStemExperimental Treatment1 Intervention
Group II: PlaceboPlacebo Group1 Intervention
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
MultiStem
Not yet FDA approved

Find a Location

Who is running the clinical trial?

Healios K.K.Lead Sponsor
12 Previous Clinical Trials
1,070 Total Patients Enrolled
Athersys, IncLead Sponsor
10 Previous Clinical Trials
829 Total Patients Enrolled
Anthony Ting, PhDStudy DirectorAthersys, Inc
Eric Jenkins, MDStudy DirectorHealios K.K.

Media Library

MultiStem (Stem Cell Therapy) Clinical Trial Eligibility Overview. Trial Name: NCT04367077 — Phase 2 & 3
Acute Respiratory Distress Syndrome Research Study Groups: MultiStem, Placebo
Acute Respiratory Distress Syndrome Clinical Trial 2023: MultiStem Highlights & Side Effects. Trial Name: NCT04367077 — Phase 2 & 3
MultiStem (Stem Cell Therapy) 2023 Treatment Timeline for Medical Study. Trial Name: NCT04367077 — Phase 2 & 3
~72 spots leftby Dec 2025
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top